Viva Biotech Holdings (HKSE:01873) Effective Interest Rate on Debt % : 3.18% (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Viva Biotech Holdings's annualized positive value of Interest Expense for the quarter that ended in Dec. 2024 was HK$48 Mil. Viva Biotech Holdings's average total debt for the quarter that ended in Dec. 2024 was HK$1,515 Mil. Therefore, Viva Biotech Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2024 was 3.18%.

Viva Biotech Holdings Effective Interest Rate on Debt % Historical Data

The historical data trend for Viva Biotech Holdings's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings Effective Interest Rate on Debt % Chart

Viva Biotech Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

4.12

6.62

6.44

7.38

3.33

Viva Biotech Holdings Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Effective Interest Rate on Debt %	Get a 7-Day Free Trial											6.62	6.08	7.37	3.61	3.18

Competitive Comparison of Viva Biotech Holdings's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Viva Biotech Holdings's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Viva Biotech Holdings's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Viva Biotech Holdings's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Viva Biotech Holdings's Effective Interest Rate on Debt % falls into.

Save Embed

;

Save Embed

;

Viva Biotech Holdings Effective Interest Rate on Debt % Calculation

Viva Biotech Holdings's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2023 )	+	Total Debt (A: Dec. 2024 ))	/ count )
=	-1 * -57.539	/	( (2081.699	+	1370.946)	/ 2 )
=	-1 * -57.539	/	1726.3225
=	3.33 %

where

	Total Debt (A: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	1039.939	+	1041.76
=	2081.699

	Total Debt (A: Dec. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	781.074	+	589.872
=	1370.946

Viva Biotech Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Jun. 2024 )	+	Total Debt (Q: Dec. 2024 ))	/ count )
=	-1 * -48.132	/	( (1658.965	+	1370.946)	/ 2 )
=	-1 * -48.132	/	1514.9555
=	3.18 %

where

	Total Debt (Q: Jun. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	955.897	+	703.068
=	1658.965

	Total Debt (Q: Dec. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	781.074	+	589.872
=	1370.946

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Dec. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Viva Biotech Holdings (HKSE:01873) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Viva Biotech Holdings Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Viva Biotech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (HKSE:01873) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

VBIZF:USA VB0:Germany

Address

735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318

Website

https://www.vivabiotech.com

Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.

Executives

Mao Chen Cheney	2101 Beneficial owner
Temasek Holdings (private) Limited	2201 Interest of corporation controlled by you
Mao Jun	2501 Other
Wu John Jiong	2201 Interest of corporation controlled by you
Fenghe Harvest Ltd	2101 Beneficial owner
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Zhou Min	2202 Interest of your spouse
Intertrust (singapore) Ltd.	2301 Trustee
Z&m International Holdings Limited	2201 Interest of corporation controlled by you
Zhang And Sons Limited	2101 Beneficial owner

Viva Biotech Holdings Headlines

No Headlines